Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
Inga-Maria Launonen(University of Helsinki), Anniina Färkkilä(University of Helsinki)
Cited by 56
Related Papers
Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
|Nature Communications|2020|342
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunotherapy
|Cancer Discovery|2020|138
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
|Nature Communications|2022|121
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
|Nature Communications|2020|13